FDA To Probe Prostate Cancer Drug Class
A class of prostate cancer drugs marketed by Pfizer Inc., Sanofi-Aventis SA and Bayer AG may be linked to an increased risk of health issues, including sudden death, and will be...To view the full article, register now.
Already a subscriber? Click here to view full article